Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0283
Source ID: NCT04661917
Associated Drug: Bay2327949
Title: A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.
Acronym: ASSESS-CKD
Status: WITHDRAWN
Study Results: NO
Results:
Conditions: Chronic Kidney Disease|Diabetic Kidney Disease
Interventions: DRUG: BAY2327949|DRUG: Placebo
Outcome Measures: Primary: Change from baseline in urine albumin-to-creatinine ratio (UACR) to the end of treatment (Visit 6), Baseline and Visit 6 (28 days) | Secondary: Frequency of treatment-emergent adverse events (TEAEs), From the first treatment with the study intervention until 7 days after the last dose, up to 5 weeks
Sponsor/Collaborators: Sponsor: Bayer
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 0
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2021-05-31
Completion Date: 2022-05-19
Results First Posted:
Last Update Posted: 2021-05-21
Locations: Konventhospital Barmherzige Brüder Linz, Linz, Oberösterreich, 4021, Austria|Medizinische Universität Graz, Graz, Steiermark, 8036, Austria|Landeskrankenhaus Feldkirch, Feldkirch, Vorarlberg, 6807, Austria|Universitätsklinikum St. Pölten, St. Pölten, 3100, Austria|Zentrum f. klinische Studien Dr. Hanusch GmbH, Wien, 1060, Austria|Universitätsklinikum AKH Wien, Wien, 1090, Austria|Klinik Hietzing, Wien, 1130, Austria|Aarhus Universitetshospital, Skejby, Aarhus N, 8200, Denmark|Sydvestjysk Sygehus Esbjerg, Esbjerg, 6700, Denmark|Regionshospitalet Herning, Herning, 7400, Denmark|Nordsjællands Hospital, Hillerød, 3400, Denmark|Hvidovre Hospital, Hvidovre, 2650, Denmark|Odense Universitetshospital, Odense C, DK-5000, Denmark|Health Step Finland Oy, Kuopio, 70100, Finland|Päijät-Hämeen keskussairaala, Lahti, 15850, Finland|Oulun yliopistollinen sairaala, Oulu, 90220, Finland|Seinäjoen keskussairaala, Seinäjoki, FIN 60220, Finland|Turun yliopistollinen keskussairaala, kantasairaala, Turku, 20520, Finland|Academisch Medisch Centrum (AMC), Amsterdam, 1105 AZ, Netherlands|Albert Schweitzer Ziekenhuis, Locatie Dordwijk, Dordrecht, 3318 AT, Netherlands|Maxima Medisch Centrum, locatie Eindhoven, Eindhoven, 5600 PD, Netherlands|Albert Schweitzer Ziekenhuis, locatie Zwijndrecht, Zwijndrecht, 3331 LZ, Netherlands|AKTIMED Helse AS, Hamar, 2317, Norway|Sykehuset Innlandet HF Hamar, Hamar, 2326, Norway|Oslo Universitetssykehus HF, Rikshospitalet, Oslo, 0586, Norway|Skedsmo Medisinske Senter, Skedsmokorset, 2020, Norway|Stavanger Helseforskning AS, Stavanger, 4011, Norway|St. Olavs Hospital HF, Trondheim, 7006, Norway|Carlanderska Sjukhuset, Göteborg, 405 45, Sweden|ProbarE, Lund, 222 22, Sweden|Dalecarlia Clinical Research, Rättvik, 795 30, Sweden|Center For Diabetes, Academic Specialist Center, Stockholm, 113 65, Sweden|Akademiska Sjukhuset, Uppsala, 751 85, Sweden|Kantonsspital St. Gallen, St. Gallen, Sankt Gallen, 9007, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Vaud, 1011, Switzerland|Inselspital Universitätsspital Bern, Bern, 3010, Switzerland
URL: https://clinicaltrials.gov/show/NCT04661917

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress